SERPINA1 and chronic obstructive pulmonary disease: Regarding COPD, only two biomarkers are now considered in guidelines: one is alpha1 antitrypsin (AAT) status (AAT deficiency affects a small minority of emphysematous patients), the other, introduced very recently, is blood eosinophil count [1].